Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,58 USD | -0,65% | -5,95% | -23,54% |
Omzet 2024 * | 397 mln. 371 mln. | Omzet 2025 * | 486 mln. 455 mln. | Marktkapitalisatie | 944 mln. 883 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -126 mln. -118 mln. | Nettowinst (verlies) 2025 * | -63 mln. -58,95 mln. | EV/omzet 2024 * | 2,97 x |
Nettoschuld 2024 * | 234 mln. 219 mln. | Nettoschuld 2025 * | 259 mln. 242 mln. | EV/omzet 2025 * | 2,47 x |
K/w-verhouding 2024 * |
-7,38
x | K/w-verhouding 2025 * |
-13,7
x | Werknemers | 536 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,92% |
Recentste transcriptie over BioCryst Pharmaceuticals, Inc.
1 dag | -0,65% | ||
1 week | -5,95% | ||
Lopende maand | -9,84% | ||
1 maand | -8,40% | ||
3 maanden | -23,15% | ||
6 maanden | -21,84% | ||
Lopend jaar | -23,54% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jon Stonehouse
CEO | Chief Executive Officer | 63 | 01-01-07 |
Anthony Doyle
DFI | Director of Finance/CFO | 44 | 02-04-20 |
Michael Jones
DFI | Director of Finance/CFO | 54 | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Levin
BRD | Director/Board Member | 62 | 27-02-20 |
Jon Stonehouse
CEO | Chief Executive Officer | 63 | 01-01-07 |
Director/Board Member | 60 | 26-07-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.23% | 0 M€ | 0,00% | - | |
0.20% | 0 M€ | 0,00% | - | |
0.18% | 1 026 M€ | +6,04% | - | |
0.13% | 509 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 4,58 | -0,65% | 4 055 194 |
16-04-24 | 4,61 | -1,28% | 1 979 399 |
15-04-24 | 4,67 | -2,10% | 2 496 660 |
12-04-24 | 4,77 | -6,47% | 4 525 575 |
11-04-24 | 5,1 | +4,72% | 3 304 258 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,54% | 944 mln. | |
-3,39% | 102 mld. | |
+2,61% | 96,84 mld. | |
-1,51% | 21,48 mld. | |
-18,14% | 20,82 mld. | |
-6,87% | 18,6 mld. | |
-40,70% | 16,81 mld. | |
-26,89% | 13,78 mld. | |
+1,12% | 13,4 mld. | |
+22,25% | 11,06 mld. |